Thursday, June 11, 2026

Intelligence Β· INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 134 of 200 Β· By data quality, then INN

  1. piflufolastat (18f)

    PYLCLARI

    EMA: approved

    V09
  2. piperaquine tetraphosphate

    EURARTESIM

    EMA: approved

    P01BF05
  3. pixantrone dimaleate

    PIXUVRI

    EMA: unknown

    L01DB11
  4. plazomicin (sulfate)

    ZEMDRI

    EMA: application withdrawn

  5. plitidepsin

    APLIDIN

    EMA: application withdrawn

    L01
  6. pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)

    PREVENAR 13

    EMA: approved

    J07AL02
  7. pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed)

    PREVENAR 20 (PREVIOUSLY APEXXNAR)

    EMA: approved

    J07AL02
  8. pneumococcal polysaccharide conjugate vaccine (21-valent)

    CAPVAXIVE

    EMA: approved

    J07AL02
  9. pneumococcal polysaccharide conjugate vaccine (adsorbed)

    SYNFLORIX

    EMA: approved

    J07AL52
  10. pneumococcal saccharide conjugated vaccine, adsorbed

    PREVENAR

    EMA: withdrawn

    J07AL02
  11. polatuzumab vedotin

    POLIVY

    EMA: approved

    L01FX14
  12. polihexanide

    AKANTIOR

    EMA: approved

    S01AX24
  13. ponatinib

    ICLUSIG Lacuna Pharma Pty Ltd

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01EA05
  14. prasugrel

    PRASUGREL LUPIN

    EMA: approved Β· TGA: approved

    B01AC22
  15. prepandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted)

    PREPANDRIX

    EMA: withdrawn

    J07BB02
  16. prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted)

    PREPANDEMIC INFLUENZA VACCINE (H5N1) (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED) NOVARTIS VACCINES AND DIAGNOSTICS

    EMA: unknown

    J07BB02
  17. prepandemic influenza vaccine (h5n1) (whole virion, inactivated,prepared in cell culture)

    VEPACEL

    EMA: withdrawn

    J07BB01
  18. pridopidine

    NURZIGMA

    EMA: application withdrawn

    N07
  19. propranolol

    APO-PROPRANOLOL Alphapharm Pty Ltd

    EMA: approved Β· TGA: approved

    C07AA05
  20. quadrivalent influenza vaccine (recombinant, prepared in cell culture)

    SUPEMTEK TETRA (PREVIOUSLY SUPEMTEK)

    EMA: approved

    J07BB02
  21. quizartinib

    VANFLYTA

    EMA: approved

    L01EX11
  22. radium ra223 dichloride

    XOFIGO

    EMA: approved

    V10XX03
  23. raltegravir

    ISENTRESS Merck KGaA, Darmstadt, Germany

    EMA: approved Β· TGA: approved

    J05AJ01
  24. ravulizumab

    ULTOMIRIS Lacuna Pharma Pty Ltd

    EMA: approved Β· TGA: approved

    L04AA43

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.